![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 38/26 | (2006.01) |
A61K 45/06 | (2006.01) | ||
A61K 9/20 | (2006.01) | ||
A61K 47/12 | (2006.01) | ||
A61P 3/10 | (2006.01) |
(11) | Number of the document | 3746111 |
(13) | Kind of document | T |
(96) | European patent application number | 19702275.9 |
Date of filing the European patent application | 2019-02-01 | |
(97) | Date of publication of the European application | 2020-12-09 |
(45) | Date of publication and mention of the grant of the patent | 2023-07-19 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2019/052487 |
Date | 2019-02-01 |
(87) | Number | WO 2019/149880 |
Date | 2019-08-08 |
(30) | Number | Date | Country code |
18154913 | 2018-02-02 | EP |
(72) |
PEDERSEN, Betty, Lomstein , DK
NISSEN, Birgitte , DK
|
(73) |
Novo Nordisk A/S ,
Novo Allé, 2880 Bagsværd,
DK
|
(54) | SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST, A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID AND A LUBRICANT |
SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST, A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID AND A LUBRICANT |